Evidence map›Paper›PMID 20496014›Full record

ReviewInternal and emergency medicine2010

Angioedema due to C1 inhibitor deficiency in 2010.

Marco Cicardi, Andrea Zanichelli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Internal and emergency medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A case of hereditary angioedema in a 7-year-old korean girl.Allergy, asthma & immunology research · 2013
    Article
  10. Article
  11. "Surgical" abdomen in a patient with chronic lymphocytic leukemia: a case of acquired angioedema.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Marco CicardiDipartimento di Scienze Cliniche Luigi Sacco, Università di Milano, Ospedale L. Sacco, Milan, Italy. Marco.Cicardi@unimi.it
Andrea Zanichelli
Luigi Sacco Hospital · ITUniversity of Milan · IT

Funding

Telethon GGP08223
6 · The paper itself

Abstract

Angioedema is a recurrent, non-pitting, non-pruritic, self-limiting swelling due to transient increase of endothelial permeability in the capillaries of the deep cutaneous and mucosal layers. Two main groups of angioedema should be distinguished based on the response to treatment: those responding to antihistamine and those that do not. Among the last ones, angioedema due to inherited (hereditary angioedema) and acquired (acquired angioedema) C1 inhibitor deficiency are the best defined, and are known to be mediated by bradykinin. The clinical picture is characterized by cutaneous, abdominal, and laryngeal symptoms that are highly disabling, and can be lethal when they affect the larynx, or if they are not promptly and adequately treated. Important advances in diagnosis and treatment of C1 inhibitor deficiency have been made in recent years, and today, we can rely on different therapeutic options to prevent symptoms or to treat those already present. Because of these advances, in patients properly diagnosed and treated, the mortality for the disease has dropped close to zero, and the quality of life for patients approaches that of normal subjects.

Indexed as

Adrenergic beta-AntagonistsAlgorithmsBradykininComplement C1 Inhibitor ProteinComplement Inactivating AgentsHereditary Angioedema Types I and IIHumansAdrenergic beta-AntagonistsBradykininComplement C1 Inhibitor ProteinComplement Inactivating Agentsicatibant

Identifiers

PMID20496014
OpenAlexW2056224514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.